Taiwan FDA registration a347aec9bb39ff20031ba96e8902053a
Primsulis non-invasive treatment device
TW: 先舒立非侵入式治療裝置
Taiwan·Risk Class 2·DAEYANG MEDICAL Co., Ltd·Registered Oct 04, 2021 – Oct 04, 2026ActiveRegistration details
- Analysis ID
- a347aec9bb39ff20031ba96e8902053a
- Customs Code
- DHA05603486805
Company information
- Manufacturer
- DAEYANG MEDICAL Co., Ltd
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- CLOVERS BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- It is used for pelvic floor muscle strengthening in the treatment of urinary incontinence.
- Product Type (Level 1)
- H 胃腸病科學及泌尿科學;; O 物理醫學科學
- Product Type (Level 2)
- H.5320 Non-implantable electronic urination home-made device;; O.5850 Powered Muscle Stimulator
- Import Information
- import
Dates and status
- Registration Date
- Oct 04, 2021
- Expiry Date
- Oct 04, 2026
About this record
Access comprehensive regulatory information for Primsulis non-invasive treatment device in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a347aec9bb39ff20031ba96e8902053a and manufactured by DAEYANG MEDICAL Co., Ltd. The authorized representative in Taiwan is CLOVERS BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices